Bevacizumab and Retinal Vascular Occlusions

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2006 by Asociación para Evitar la Ceguera en México.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México
ClinicalTrials.gov Identifier:
NCT00347711
First received: June 30, 2006
Last updated: July 3, 2006
Last verified: June 2006
  Purpose

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.


Condition Intervention Phase
Edema Macular
Vascular Occlusion
Drug: Intravitreal injection
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by Asociación para Evitar la Ceguera en México:

  Eligibility

Ages Eligible for Study:   40 Years to 90 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Vascular occlusion and edema macular diagnosticated by fluorescein angiography and coherent optic tomography

Exclusion Criteria:

  • Previous surgery
  • Uveitis
  • Glaucoma
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00347711

Locations
Mexico
Asociacion para Evitar la Ceguera en Mexico Recruiting
Mexico, D.F. Mexico, Mexico, 04030
Contact: Griselda Alvarez, Fellow    5255 10841400 ext 1171    retinamex@yahoo.com.   
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Griselda Alvarez, Fellow APEC
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00347711     History of Changes
Other Study ID Numbers: APEC-0020
Study First Received: June 30, 2006
Last Updated: July 3, 2006
Health Authority: Mexico: Secretaria de Salud

Additional relevant MeSH terms:
Macular Edema
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases

ClinicalTrials.gov processed this record on April 15, 2014